Lung Cancer

In this video, Ravi Salgia, MD, PhD, discussed the 2022 Excellence in Teaching Award he received at ASCO Annual Meeting.

In this edition, Incidental respiratory findings on low-dose CT lung cancer screening common; lack of guideline-concordant treatment for early-stage non-small cell lung cancer common; women at greater risk for more severe adverse events from cancer treatments, and more.

Most patients with non-small cell lung cancer had an adequate antibody response to COVID-19 vaccines, research published in Journal of Clinical Oncology showed.

The Healio Editors compiled the most-read news in pulmonology posted in May.

Alex A. Adjei, MD, PhD, has been appointed chair of Cleveland Clinic Taussig Cancer Institute.

CHICAGO — Adding tiragolumab, an anti-TIGIT agent, to atezolizumab and carboplatin plus etoposide did not provide more benefit compared with atezolizumab and carboplatin plus etoposide alone, according to findings from SKYSCRAPER-02 trial.

In this video, Melina Marmarelis, MD, highlights findings from a Lung-MAP nonmatched substudy presented at ASCO Annual Meeting.

In this video, Jia Luo, MD, spoke with Healio about an educational session she chaired at ASCO Annual Meeting.

Men, older patients and patients with low income were among those with elevated risk for CVD hospitalization prior to receiving a diagnosis of potentially curable cancer, researchers reported.

New lung cancer screening guidance from the U.S. Preventive Services Task Force, which lowered the age for inclusion and intensity of smoking to qualify as high risk, resulted in an increase in the proportion of Black individuals screened.